Literature DB >> 18047430

Clinical features and therapeutic implication of papillary thyroid microcarcinoma.

Kalliopi Pazaitou-Panayiotou1, Marco Capezzone, Furio Pacini.   

Abstract

Papillary thyroid microcarcinomas (PTMs) are small tumors (< or =1 cm of diameter) that belong to the well-differentiated low-risk carcinomas of the thyroid, which are characterized by benign behavior, probably of little clinical significance, and do not affect patients' survival. They are found in otherwise normal thyroids or in multinodular goiters with a clinical frequency varying substantially according to different series. Sometimes, PTM may be associated with lymph node metastases at presentation and/or locoregional recurrences during follow-up. Distant metastases are extremely rare, but have been reported. Although deaths related to PTM are almost unknown, PTM raises therapeutic implications. This review addresses the issue of definition, treatment, and follow-up of PTM.

Entities:  

Mesh:

Year:  2007        PMID: 18047430     DOI: 10.1089/thy.2007.0005

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  35 in total

1.  Decision analysis of discordant thyroid nodule biopsy guideline criteria.

Authors:  Christopher R McCartney; George J Stukenborg
Journal:  J Clin Endocrinol Metab       Date:  2008-05-27       Impact factor: 5.958

Review 2.  Thyroid nodules.

Authors:  Geanina Popoveniuc; Jacqueline Jonklaas
Journal:  Med Clin North Am       Date:  2012-03       Impact factor: 5.456

Review 3.  Diagnostic utility of galectin-3 in thyroid cancer.

Authors:  Connie G Chiu; Scott S Strugnell; Obi L Griffith; Steven J M Jones; Allen M Gown; Blair Walker; Ivan R Nabi; Sam M Wiseman
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

4.  Retrospective Analysis of 255 Papillary Thyroid Carcinomas ≤2 cm: Clinicohistological Features and Prognostic Factors.

Authors:  Pedro Marques; Valeriano Leite; Maria João Bugalho
Journal:  Eur Thyroid J       Date:  2014-12-06

5.  Follow-up ultrasound may be enough for thyroid nodules from 5 mm to 1 cm in size.

Authors:  Soo-Yeon Kim; Hye Sun Lee; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Jung Hwa Hong; Jin Young Kwak
Journal:  Endocrine       Date:  2015-09-22       Impact factor: 3.633

6.  Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.

Authors:  Celestino P Lombardi; Rocco Bellantone; Carmela De Crea; Nunzia C Paladino; Guido Fadda; Massimo Salvatori; Marco Raffaelli
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 7.  Prognostic utility of BRAF mutation in papillary thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Mol Cell Endocrinol       Date:  2009-10-31       Impact factor: 4.102

8.  Expression of hypoxia-inducible factor 1 alpha in papillary thyroid carcinoma is associated with desmoplastic stromal reaction and lymph node metastasis.

Authors:  Oskar Koperek; Erol Akin; Reza Asari; Bruno Niederle; Nikolaus Neuhold
Journal:  Virchows Arch       Date:  2013-10-03       Impact factor: 4.064

9.  Papillary thyroid microcarcinomas: big decisions for a small tumor.

Authors:  Megan Rist Haymart; Max Cayo; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2009-08-04       Impact factor: 5.344

10.  Cervical masses as manifestation of papillary thyroid carcinomas </=10 mm in diameter, in patients with unknown thyroid disease.

Authors:  Kalliopi Pazaitou-Panayiotou; Maria Alevizaki; Maria Boudina; Apostolos Drimonitis; Anastasia Kiziridou; Iraklis Vainas
Journal:  Thyroid Res       Date:  2008-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.